Literature DB >> 19002355

Severe cutaneous reaction to sorafenib: induction of tolerance.

Carolyn Bauer, Bernhard Przybilla, Franziska Ruëff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19002355     DOI： 10.2340/00015555-0517

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

1.  Systemic steroid treatment can desensitize the skin reaction due to regorafenib in a recurrence colorectal cancer patient.

Authors:  Keita Tashiro; Eiji Shinto; Yoshiki Kajiwara; Satsuki Mochizuki; Koichi Okamoto; Aya Nishizawa; Takahiro Satoh; Yoji Kishi; Hideki Ueno
Journal:  Int Cancer Conf J       Date:  2019-05-24

2.  Sorafenib-associated facial acneiform eruption.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2014-12-25

3.  Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity.

Authors:  Naoki Yoshioka; Teiji Kuzuya; Takanori Ito; Yoji Ishizu; Takashi Honda; Tetsuya Ishikawa; Masatoshi Ishigami; Mitsuhiro Fujishiro
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

4.  Case Report: Severe rash/desquamation induced by sorafenib in an uHCC patient and its clinical management.

Authors:  Yan Lin; Ping-Yu Liu
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.